We thank Patrick Chambers for his interest [] in our recently published paper on the vitamin D status in COVID-19 patients in the Romanian population []. Our study is a cross-sectional one, based solely on observational results and is not a randomized controlled one. We also stated that our patients did not receive a vitamin D treatment during the hospitalization, nor vitamin C (as vitamin C was mentioned in the commentary); we also did not state a dose recommendation for vitamin D supplementation neither in healthy nor in SARS-CoV-2-infected subjects.
The recommended thresholds for the vitamin D status, as well as the daily dose recommendation, both for bone homeostasis as well for extra-skeletal effects, including COVID-19, are still controversial, as recently reviewed by Bouillon R et al. []. Many factors drive these controversial results: different cut-off definitions, confounding factors, or different sampling moments. Although we are aware that the extra-skeletal effects of vitamin D are effective at higher serum levels, probably above 50 ng/mL, in our study we were not able to set this high threshold due to statistical reasons, since only a small number of subjects had reached this threshold.
A study published in JAMA by Murrai et al. that found no effect of high bolus-dose of vitamin D in COVID-19 patients used a baseline vitamin D level of 20 ng/mL []; however, the vitamin D supplementation reduced the acute respiratory infections, the daily dose is preferred upon intermittent dosage, and the lower the vitamin D levels, the greater the beneficial effects of vitamin D supplementation results [].
In our study, there was no intention to assess the magnesium and calcium serum status; it was an evaluation of the vitamin D status in Romanian hospitalized COVID-19 patients. While the threshold values for blood levels are not yet universally accepted, they are not subject to on/off effects. We believe that evaluating the continuum of values in particular populations can still be meaningful.
Dr. Fauci’s personal preferences of supplements are undoubtedly informative but nevertheless cannot rank per se above the level of expert opinion.
Author Contributions
Conceptualization, A.H. and A.M.G.; methodology, A.H.; software, S.V.; validation, A.H., A.M.G. and M.D.; formal analysis, A.H. and A.M.G.; investigation, A.V.A., V.N. and A.H.; data curation, A.H., S.V. and A.V.A.; writing—original draft preparation, A.H. and A.M.G.; writing—review and editing, A.M.G. and M.D.; supervision, M.D. and A.M.G.; project administration, A.H.; funding acquisition, A.H. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania, grant number 10126/1/17.12.2020 and the publication fee is supported by George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Chambers, P. Comment on Huțanu et al. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998. Nutrients 2022, 14, 3387. [Google Scholar] [CrossRef]
- Huțanu, A.; Georgescu, A.M.; Voidăzan, S.; Andrejkovits, A.V.; Negrea, V.; Dobreanu, M. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients’ Outcomes—A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022, 14, 1998. [Google Scholar] [CrossRef] [PubMed]
- Bouillon, R.; Manousaki, D.; Rosen, C.; Trajanoska, K.; Rivadeneira, F.; Richards, J.B. The health effects of vitamin D supplementation: Evidence from human studies. Nat. Rev. Endocrinol. 2022, 18, 96–110. [Google Scholar] [CrossRef] [PubMed]
- Murai, H.I.; Fernandes, A.L.; Sales, P.L.; Pinto, A.; Goessler, K.; Duran, C.S.; Silva, C.B.R.; Franco, A.S.; Macedo, M.B.; Dalmolin, H.H.H.; et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients with Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA 2021, 325, 1053–1060. [Google Scholar] [CrossRef] [PubMed]
- Martineau, A.R.; Jolliffe, D.A.; Greenberg, L.; Aloia, J.F.; Bergman, P.; Dubnov-Raz, G.; Esposito, S.; Ganmaa, D.; Ginde, A.A.; Goodall, E.C.; et al. Vitamin D supplementation to prevent acute respiratory infections: Individual participant data meta-analysis. Health Technol. Assess. 2019, 23, 1–44. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).